Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Opexa Therapeutics (OPXA)

0.672 -0.038 (-5.325%)

4/27/2017  12:18pm

Open:

0.682

Pre. Close:

0.710

High:

0.700

Low:

0.672

Volume:

14,895

Market Cap:

5.15M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.77 - 0.86

0.86 - 1.05

Low:

0.61 - 0.63

0.63 - 0.66

Close:

0.68 - 0.75

0.75 - 0.89

Technical analysis  (as of: 2017-04-27 11:59:16 AM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 0.90     One year:

Support:

Support1: 0.62    Support2: 0.52

Resistance:

Resistance1: 0.77    Resistance2: 0.86

Pivot:

0.68

Moving Averages:

MA(5): 0.68     MA(20): 0.70

MA(100): 0.90     MA(250): 2.26

MACD:

MACD(12,26): -0.04     Signal(12,26,9): -0.05

%K %D:

%K(14,3): 39.63     %D(3): 33.57

RSI:

RSI(14): 42.95

52-Week:

High: 4.930  Low: 0.500  Change(%): -71.5

Average Vol(K):

3-Month: 262  10-Days 102

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
OPXA has closed below upper band by 47.2%. Bollinger Bands are 48.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to OPXA's normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 27 Apr 2017 09:11:15 GMT
Opexa Therapeutics Inc (OPXA) Rating Increased to Hold at Zacks Investment ...

Mon, 16 Jan 2017 14:27:04 GMT
Opexa Therapeutics Inc (NASDAQ:OPXA) Is A Buyout Target; But Not For Its Pipeline

Sat, 12 Feb 2011 05:36:17 GMT
Opexa Therapeutics Inc. OPXA (US: Nasdaq)

Mon, 16 Jan 2017 13:18:45 GMT
Opexa Therapeutics Inc (NASDAQ:OPXA) Closes In Red

Tue, 25 Apr 2017 10:52:30 GMT
Short Interest in Opexa Therapeutics Inc (OPXA) Decreases By 4.3%

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

7.14

Shares Float (M)

7.55

% Held by Insiders

9.33

% Held by Institutions

4.90

Shares Short (K)

673

Shares Short Prior Month (K)

683

Stock Financials

EPS

-1.130

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

Book Value (p.s.)

0.380

PEG Ratio

Profit Margin

-274.69

Operating Margin

-239.33

Return on Assets (ttm)

-47.5

Return on Equity (ttm)

-129.5

Qtrly Rev. Growth

21.4

Gross Profit (p.s.)

0.408

Sales Per Share

0.408

EBITDA (p.s.)

-0.940

Qtrly Earnings Growth

Operating Cash Flow (M)

-9.20

Levered Free Cash Flow (M)

-6.89

FoxReading.com

Valuation

P/E

-0.61

P/E Growth Ratio

-0.04

P/BV

1.80

P/S

1.68

P/CF

-0.53

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2012-12-17

Last Split Ratio

0.25

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.